Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

105.84 -3.91 (-3.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
NASDAQ:LNTH is not too expensive for the growth it is showing. 
Via Chartmill
Why NASDAQ:LNTH Is a Promising High-Growth Stock in the Midst of Consolidation.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): a strong growth stock preparing for the next leg up?. 
Via Chartmill
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Appoints Julie Eastland as New Board Member
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is not too expensive for the growth it is showing.
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced. 
Via Chartmill
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced. 
Via Chartmill
NASDAQ:LNTH, an undervalued stock with good fundamentals.
Despite its impressive fundamentals, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) remains undervalued. 
Via Chartmill
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
In the world of growth stocks, NASDAQ:LNTH shines as a value proposition. 
Via Chartmill
Bargain Hunting for Stocks: 2 Stocks to Buy in September
Even with the market near all-time highs, there are bargains to be found. 
Via The Motley Fool
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Why NASDAQ:LNTH Is a Promising High-Growth Stock in the Midst of Consolidation.
Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Don't overlook LANTHEUS HOLDINGS INC (NASDAQ:LNTH)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
Lantheus Reports Second Quarter 2024 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Russell 2000 Marks Fifth Day Of Gains: What's Driving Surge In Small-Cap Stocks?
Small-cap stocks, including Comfort Systems USA, Fabrinet, and Carvana, have rallied for 5 days, with iShares Russell 2000 ETF up 9% in 5 sessions. 
Via Benzinga
Topics ETFs
Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks
The IWM ETF broke above multi-year resistance last week, driven by lower-than-expected June inflation data, leading to a weekly gain of 6.11%. 
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
Acquisition Expands Pipeline and Strengthens Alzheimer’s Diagnostic Capabilities 
From Lantheus Holdings, Inc.
Via GlobeNewswire
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit... 
Via Benzinga
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
Megacaps and chip plays tumbled Thursday, but mostly still have healthy charts. 
Via Investor's Business Daily
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
New Reimbursement Rules For Diagnostic Radiopharmaceuticals Is 'Undoubtedly' Positive for Lantheus: Analyst
CMS proposes new Medicare payment rates for 2025, addressing diagnostic radiopharmaceutical costs. The proposed rule includes separate payments for high-cost radiopharmaceuticals over $630, benefiting... 
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
From Lantheus Holdings, Inc.
Via GlobeNewswire
Why Lantheus Holdings Stock Is Skyrocketing Today
Investors are cheering a proposed rule that could boost Lantheus' revenue. 
Via The Motley Fool
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Lantheus Stock Gets A Radioactive Surge On Medicare Proposal
The company is in the business of radiopharmaceutical diagnostics and drugs. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.